Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3093% above fair value
$19.94−1.06 (-5.05%)
Close on Nov 17, 2026Market cap $5.63BP/E –Yield –
Caris Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Caris Life Sciences's operating cash flow for the twelve months ending Sep 30, 2026 was $83.89M. For fiscal 2025 it was $83.16M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.16M | – |
| FY2024 | Dec 31, 2024 | -$245.20M | – |
| FY2023 | Dec 31, 2023 | -$276.10M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$22.25M | -135.6% |
| Q2 FY2026 | Jun 30, 2026 | $28.48M | +290.7% |
| Q1 FY2026 | Mar 31, 2026 | $32.88M | – |
| Q4 FY2025 | Dec 31, 2025 | $44.78M | – |
| Q3 FY2025 | Sep 30, 2025 | $62.43M | – |
| Q2 FY2025 | Jun 30, 2025 | $7.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$31.34M | – |
| Q4 FY2024 | Dec 31, 2024 | -$38.92M | – |
| Q3 FY2024 | Sep 30, 2024 | -$69.43M | – |
See a number that looks wrong?